Latest News
Invest in the Top S&P Stocks With This New ETF
Exchange-traded funds (ETFs) are often associated with a lot of diversification. People often invest ...
5 Dividend Stocks to Double Up on Right Now -- Plus Some Dividend ETFs
It's hard to beat the power of dividend-paying stocks. They have outperformed non-payers significantly.
AbbVie (ABBV) Q3 2024 Earnings Call Transcript
ABBV earnings call for the period ending September 30, 2024.
3 Dividend Growth Stocks to Buy and Never Sell
These 3 dividend growth stocks have crushed the market and show no signs of slowing down.
December Nasdaq 100 E-Mini futures (NQZ24) are trending up +0.28% this morning as strong quarterly results from Alphabet boosted sentiment, while investors also awaited a fresh batch of U.S. economic data and earnings reports from “Magnificent Seven” companies Microsoft and Meta.
AbbVie's VRAYLAR® (cariprazine) Now Publicly Reimbursed in Ontario
/CNW/ - AbbVie (NYSE: ABBV) announced today that Ontario has listed VRAYLAR® (cariprazine) on its provincial formulary as a General Benefit. The listing will...
3 Dividend Growth Stocks You Can Buy and Hold Forever
These healthcare stocks have fantastic dividend track records.
3 High-Yielding Dividend Stocks That Can Be Ideal Buys for Retirees
These stocks yield between 2.8% and 3.3% in dividends.
After more than doubling in the past year, is this clinical-stage biotech stock still a buy?
Beat the Nasdaq With This Cash-Gushing Dividend Stock
The company is performing well despite recently losing its biggest growth driver.
3 Simple Vanguard ETFs to Buy With $1,000 and Hold for a Lifetime
These three Vanguard ETFs are worth considering for the long term.
Nine Provinces Approve Accelerated Public Reimbursement of Diffuse Large B-Cell Lymphoma Treatment Under New Early Access Process
/CNW/ - AbbVie (NYSE: ABBV), today announced that nine (9) provinces have provided accelerated public coverage of EPKINLY™. EPKINLY is a treatment for adult...
Hunting for value? These three Dividend Aristocrats look cheap by today's valuations.
3 Growth Stocks That Could Be Bargain Buys Right Now
These stocks trade at less than 20 times their estimated future profits.
2 Magnificent Dividend Stocks to Buy and Hold Forever
These companies have compelling track records.
Big pharmaceutical firms may lack the potential for rally driven by a breakout drug like small biotechs, but stability and steady growth remain attractive.
Prediction: These 2 High-Yield Dividend Stocks Will Outperform the S&P 500 Index in the Coming Decade
Buying these stocks gives you a great chance to beat the benchmark.
There Are Only 28 S&P 500 Companies Warren Buffett Can't Buy Outright. Here's the Best of the Bunch for Income Investors.
This Dividend King is beyond Buffett's reach to fully acquire and is a great pick for income investors.
Looking for reliable yield? These three companies offer ever-increasing dividends and a lifetime of stability.
AbbVie is tracking for a new high that may be reached before the end of the year. Acquisitions fuel the growth outlook, cash flow and capital returns.
3 Magnificent Dividend Stocks to Buy in October
These dividend stocks are great picks as the fall season gets underway.
Billionaires Are Loading Up on This High-Yield Dividend Stock. Should You?
Declining earnings haven't scared billionaire investors away from this stock.
2 Top Dividend Stocks Yielding 3% or More to Buy Without Hesitation Right Now
These companies can lend growth and dividend returns to a long-term investor's portfolio.
FDA Approves 16 New Cancer Treatments as Global Cancer Rates Skyrocket
/CNW/ -- USA News Group News Commentary – While some forms of cancer are seeing death rates fall, the world is witnessing a global surge in cancers among...
5 Best Dividend Growth Stocks to Buy in October
These five stocks are known for their generous dividend programs and robust business models.